DR

Dinesh Ranchhoddas Ravani

Active Director Director DIN 10221386
DIN 10221386 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Dinesh Ranchhoddas Ravani

Data last updated:

Dinesh Ranchhoddas Ravani is a Director at Croon Pharma Private Limited (since 2023). The company operates in Pharma.

DIN 10221386
Primary Designation Director
Industry Pharma
First Appointment 30 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Croon Pharma Private Limited U46497GJ2023PTC142516
Director30 Jun 20232023Active

Board colleagues of Dinesh Ranchhoddas Ravani

Directorship timeline

Open interactive timeline →
Croon Pharma Private Limited
Premium access

Shareholding and investment profile for Dinesh Ranchhoddas Ravani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Ranchhoddas Ravani

Dinesh Ranchhoddas Ravani currently holds 1 directorship: Croon Pharma Private Limited (Director, since 30 Jun 2023).

Dinesh Ranchhoddas Ravani was first appointed on 30 Jun 2023 as Director at Croon Pharma Private Limited.

The current boards of Dinesh Ranchhoddas Ravani's companies include Kaushik Ishvarbhai Solanki (Croon Pharma Private Limited), Shiv Shantilal Malli (Croon Pharma Private Limited), Shrikant Mohanlal Dalwadi (Croon Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available